USA: +1 347 690-0211 | UK: +44 2032 894158 | JAPAN: +81 50 5806 9039 | Translate : 

report img

AI for Pharmaceutical Market By Offering (Software, Services), By Technology (Context-Aware Processing, Natural Language Processing, Machine learning, and Deep Learning), and By Application (Drug Discovery, Research & Development, Diagnosis, Epidemic Prediction, Disease Prevention, Remote Monitoring, Manufacturing, and Marketing): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026

Covid-19

Global AI for Pharmaceutical Market Size, Share

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Insights

[225+ Pages Report] According to the report published by Facts & Factors, the global AI for Pharmaceutical market was valued at approximately USD 550 Million in 2019, and is expected to generate revenue of around USD 8150 Million by 2026, growing at a CAGR of around 47% between 2020 and 2026.

logoMarket Overview              

AI in pharmaceutical applications refers to the system of automated and interconnected technologies that are able to function autonomously and requires a very minute or no human interventions. AI analyses the colossal amount of data by utilizing techniques like deep learning, machine learning, adaptive learning, natural language processing, and computer vision. Both the biopharmaceutical and pharmaceutical companies are leveraging AI for various applications including drug development, drug discovery, and drug commercialization.

logoIndustry Growth Factors

The increasing adoption of artificial intelligence platforms (AIs) to reduce the overall cost of drug discovery and to boost the results is expected to boost pharmaceutical demand for these platforms. Moreover, the ease of obtaining monumental data through preclinical research and molecular screening is propelling the adoption of artificial intelligence in pharma applications. Furthermore, the accessibility of myriad options for gathering information and customization of artificial intelligence platforms is encouraging pharma companies to leverage artificial intelligence. The advancement in artificial intelligence technology enables companies to accurately recognize the molecular binding characteristics of the drug.

AI for Pharmaceutical Market

logoSegmentation Analysis

The AI for Pharmaceutical market has been analyzed into the offering, technology, and application. The offering segment has been classified into software, and services. The software segment dominants the market in 2019 owing to certain advantages such as low cost and accelerate time to market the drug. Moreover, higher demand for the software among the larger pharma, biotech manufacturer, and research institutes are significantly influencing the growth of the segment. On the basis of technology, the market has been analyzed into natural language processing, context-aware processing, deep learning, and machine learning. In terms of application, the industry has been bifurcated into manufacturing, remote monitoring, research & development, drug discovery, epidemic prediction, diagnosis, disease prevention, and marketing.

logo Regional Analysis

Geographically, North America is dominating the global market for AI for pharmaceutical. The regional market share is mainly driven by U.S. and Canada; massive investments in AI technologies and a large number of cross-industry strategic collaborations majorly fuel the growth of the AI for pharmaceutical market. Additionally, the presence of major market contributors such as Google, IBM, NVIDIA, Microsoft, and Intel, are headquartered in this region which is aiding the market to grow. However, Asia-Pacific is expected to register the highest CAGR growth over the projected period, owing to the rise in adoption of advanced AI technologies and the focus of major players on expanding their market presence in emerging countries of Asia. Thereby, certain factors are responsible for the large share and high growth rate of this market.

logo Competitive Players

Some main participants of the AI for Pharmaceutical market are Pfizer, Janssen Pharmaceutical, Sanofi, Novartis, Bayer, Takeda, Roche, Merck, Glaxo SmithKline, Eli Lilly, Astra Zeneca, and Allergan among others

logoAI for Pharmaceutical Market: Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of MEA

Covid-19

AI for Pharmaceutical Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Major Market Players

  • Pfizer
  • Janssen Pharmaceutical
  • Sanofi
  • Novartis
  • Bayer
  • Takeda
  • Roche
  • Merck
  • Glaxo SmithKline
  • Eli Lilly
  • Astra Zeneca
  • Allergan 

Frequently Asked Questions

Strict enforcement of laws by government authorities mandating AI for Pharmaceutical Market.
According to Facts and Factors research report, the global AI for Pharmaceutical Market accrued earnings worth approximately XX (USD Billion) in 2020 and is predicted to gain revenue of about XX(USD Billion) by 2028, is set to record a CAGR of nearly XX% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market value over the estimated timeline. The regional market surge is subject to large-scale presence of giant participants in countries such as the U.S. Apart from this, favorable compensation policies along with high acceptance of new AI for Pharmaceutical Market will drive regional market trends. With regional governments enforcing strict laws pertaining to drug abuse, the market for AI for Pharmaceutical Market in North America is set to witness exponential growth over years to come. Legalization of cannabis in countries such as Canada and U.S. through passing of acts in parliament is likely to enlarge scope of AI for Pharmaceutical Market in North America over coming decade.
why choose fnf
key questions answers

Related Reports

report img

Cryotherapy Units Market Report 2022 – 2028

[225+ Pages Report] According to Facts and Factors, the global cryotherapy unit market size was worth USD 361.4 million in 2021 and is estimated to grow to USD 487.08 million by 2028, with a compound annual growth rate (CAGR) of approximately 5.10% over the forecast period. The report analyzes the...

Published Date : 05-Aug-2022 | | Category : | Pages : 225 | Format : Read more

Inquiry for Buying Request Sample
report img

Cell Culture Media Market Report 2022 – 2028

[205+ Pages Report] According to Facts and Factors, the global cell culture media market size was worth around USD 4,716.20 million in 2021 and is estimated to grow to about USD 11,372.175 million by 2028, with a compound annual growth rate (CAGR) of approximately 15.80% over the forecast period. ...

Published Date : 05-Aug-2022 | | Category : | Pages : 205 | Format : Read more

Inquiry for Buying Request Sample